XML 171 R42.htm IDEA: XBRL DOCUMENT
v3.25.4

Restatement of Previously Issued Financial Statements (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2025 | Sep. 30, 2024
Restatement of Previously Issued Financial Statements [Abstract] |  |
Schedule of Consolidated Balance Sheets |  | Summary of Restatements - Consolidated Balance Sheets:
|  | As of September 30, 2023 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
ASSETS |  |  |  |  |  |  |  |  |  |  |
CURRENT ASSETS |  |  |  |  |  |  |  |  |  |  |
Cash |  | $ | 1,430 |  |  | $ | - |  |  |  |  | $ | 1,430 |
Prepaid expenses |  |  | 154,519 |  |  |  | - |  |  |  |  |  | 154,519 |
Advance to a related company |  |  | 97,882 |  |  |  | - |  |  |  |  |  | 97,882 |
Deposits |  |  | 127,664 |  |  |  | - |  |  |  |  |  | 127,664 |
Other receivables |  |  | 54,468 |  |  |  | - |  |  |  |  |  | 54,468 |
Total current assets |  |  | 435,963 |  |  |  | - |  |  |  |  |  | 435,963 |
OTHER ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property and equipment, net |  |  | 1,598 |  |  |  | - |  |  |  |  |  | 1,598 |
Intangible assets, net |  |  | 5,826,499 |  |  |  | (5,826,499 | ) |  | a |  |  | - |
Software, net |  |  | 337 |  |  |  | - |  |  |  |  |  | 337 |
Deferred merger costs |  |  | - |  |  |  | 704,334 |  |  | b |  |  | 704,334 |
Total non-current assets |  |  | 5,828,434 |  |  |  | (5,122,165 | ) |  | a, b |  |  | 706,269 |
Total assets |  | $ | 6,264,397 |  |  | $ | (5,122,165 | ) |  | a, b |  | $ | 1,142,232 |
LIABILITIES AND SHAREHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |  |  |
CURRENT LIABILITIES |  |  |  |  |  |  |  |  |  |  |  |  |  |
Loans from third parties |  | $ | 510,234 |  |  | $ | - |  |  |  |  | $ | 510,234 |
Other payables and accrued expenses |  |  | 348,807 |  |  |  | 41,450 |  |  | c |  |  | 390,257 |
Payable to directors |  |  | - |  |  |  | 2,231,781 |  |  | d |  |  | 2,231,781 |
Total current liabilities |  |  | 859,041 |  |  |  | 2,273,231 |  |  | c, d |  |  | 3,132,272 |
OTHER LIABILITIES |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payable to directors |  |  | 2,231,781 |  |  |  | (2,231,781 | ) |  | d |  |  | - |
Compensation payable to a shareholder |  |  | 5,756,366 |  |  |  | (418,093 | ) |  | a |  |  | 5,338,273 |
Total non-current liabilities |  |  | 7,988,147 |  |  |  | (2,649,874 | ) |  | a, d |  |  | 5,338,273 |
Total liabilities |  |  | 8,847,188 |  |  | $ | (376,643 | ) |  | a, c, d |  |  | 8,470,545 |
COMMITMENTS AND CONTINGENCIES |  |  |  |  |  |  |  |  |  |  |  |  |  |
SHAREHOLDERS’ DEFICIT |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 137,750,000* shares issued and outstanding as of September 30, 2023 |  |  | 13,775 |  |  |  | - |  |  |  |  |  | 13,775 |
Additional paid-in capital |  |  | 587,499 |  |  |  | - |  |  |  |  |  | 587,499 |
Accumulated deficit |  |  | (3,255,885 | ) |  |  | (4,727,705 | ) |  | a, b, c |  |  | (7,983,590 | )
Accumulated other comprehensive income |  |  | 71,820 |  |  |  | (17,817 | ) |  | a, b, c |  |  | 54,003 |
Total shareholders’ deficit |  |  | (2,582,791 | ) |  |  | (4,745,522 | ) |  | a, b, c |  |  | (7,328,313 | )
Total liabilities and shareholders’ deficit |  | $ | 6,264,397 |  |  | $ | (5,122,165 | ) |  | a, b, c |  | $ | 1,142,232 |
* | Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4.
Schedule of Consolidated Statements of Operations and Comprehensive loss | Summary of Restatements - Unaudited Condensed Consolidated Statements of Operations and Comprehensive loss:
|  | For the Three Months Ended June 30, 2024 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
General and administrative expenses |  | $ | 2,132,149 |  |  | $ | (119,211 | ) |  | a, c, e |  | $ | 2,012,938 |
Total operating expenses |  |  | 2,132,149 |  |  |  | (119,211 | ) |  | a, c, e |  |  | 2,012,938 |
Loss from operations |  |  | (2,132,149 | ) |  |  | 119,211 |  |  | a, c, e |  |  | (2,012,938 | )
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (5,796 | ) |  |  | 514 |  |  | e |  |  | (5,282 | )
Other expenses, net |  |  | - |  |  |  | (311 | ) |  | c |  |  | (311 | )
Total other expense, net |  |  | (5,796 | ) |  |  | 203 |  |  | c, e |  |  | (5,593 | )
Loss before income taxes |  |  | (2,137,945 | ) |  |  | 119,414 |  |  | a, c, e |  |  | (2,018,531 | )
Income tax expense |  |  | - |  |  |  | - |  |  |  |  |  | - |
Net loss |  | $ | (2,137,945 | ) |  | $ | 119,414 |  |  | a, c, e |  | $ | (2,018,531 | )
Foreign currency translation adjustment |  |  | (18,415 | ) |  |  | (1,937 | ) |  | a, c, e |  |  | (20,352 | )
Total comprehensive loss attributable to ordinary shareholders |  | $ | (2,156,360 | ) |  | $ | 117,477 |  |  | a, c, e |  | $ | (2,038,883 | )
Weighted average number of ordinary shares outstanding - basic and diluted* |  |  | 2,445,688 |  |  |  | (41 | ) |  | d |  |  | 2,445,647 |
Loss per ordinary share - basic and diluted* |  | $ | (0.87 | ) |  | $ | 0.04 |  |  | a, b, c, d e |  | $ | (0.83 | )
* | Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4 and share combination at a ratio of one-for-sixty effected on August 25, 2025 as described in Note 1.
Summary of Restatements - Unaudited Condensed Consolidated Statements of Operations and Comprehensive loss:
|  | For the Nine Months Ended June 30, 2024 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
General and administrative expenses |  | $ | 14,139,078 |  |  | $ | 2,189,882 |  |  | a, b, c, e |  | $ | 16,328,960 |
Total operating expenses |  |  | 14,139,078 |  |  |  | 2,189,882 |  |  | a, b, c, e |  |  | 16,328,960 |
Loss from operations |  |  | (14,139,078 | ) |  |  | (2,189,882 | ) |  | a, b, c, e |  |  | (16,328,960 | )
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (17,440 | ) |  |  | (345,044 | ) |  | a, c |  |  | (362,484 | )
Other expenses, net |  |  | - |  |  |  | (1,363 | ) |  | c |  |  | (1,363 | )
Total other expense, net |  |  | (17,440 | ) |  |  | (346,407 | ) |  | a, c |  |  | (363,847 | )
Loss before income taxes |  |  | (14,156,518 | ) |  |  | (2,536,289 | ) |  | a, b, c, e |  |  | (16,692,807 | )
Income tax expense |  |  | - |  |  |  | - |  |  |  |  |  | - |
Net loss |  | $ | (14,156,518 | ) |  | $ | (2,536,289 | ) |  | a, b, c, e |  | $ | (16,692,807 | )
Foreign currency translation adjustment |  |  | (29,994 | ) |  |  | (164,327 | ) |  | a, b, c, e |  |  | (194,321 | )
Total comprehensive loss attributable to ordinary shareholders |  | $ | (14,186,512 | ) |  | $ | (2,700,616 | ) |  | a, b, c, e |  | $ | (16,887,128 | )
Weighted average number of ordinary shares outstanding - basic and diluted* |  |  | 972,814 |  |  |  | 1,382,286 |  |  | d |  |  | 2,355,100 |
Loss per ordinary share - basic and diluted* |  | $ | (14.55 | ) |  | $ | 7.46 |  |  | a, b, c, d, e |  | $ | (7.09 | )
* | Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4 and share combination at a ratio of one-for-sixty effected on August 25, 2025 as described in Note 1.
| Summary of Restatements - Consolidated Statements of Operations and Comprehensive loss:
|  | For the Year Ended September 30, 2023 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |
General and administrative expenses |  | $ | 2,316,454 |  |  | $ | (1,090,953 | ) |  | a, b, c |  | $ | 1,225,501 |
Total operating expenses |  |  | 2,316,454 |  |  |  | (1,090,953 | ) |  | a, b, c |  |  | 1,225,501 |
Loss from operations |  |  | (2,316,454 | ) |  |  | 1,090,953 |  |  | a, b, c |  |  | (1,225,501 | )
Other income (expenses) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  | (24,207 | ) |  |  | (592,191 | ) |  | a |  |  | (616,398 | )
Total other expense, net |  |  | (24,207 | ) |  |  | (592,191 | ) |  | a |  |  | (616,398 | )
Loss before income taxes |  |  | (2,340,661 | ) |  |  | 498,762 |  |  | a, b, c |  |  | (1,841,899 | )
Income tax expense |  |  | - |  |  |  | - |  |  |  |  |  | - |
Net loss |  | $ | (2,340,661 | ) |  | $ | 498,762 |  |  | a, b, c |  | $ | (1,841,899 | )
Foreign currency translation adjustment |  |  | 68,394 |  |  |  | 55,604 |  |  | a, b |  |  | 123,998 |
Total comprehensive loss attributable to ordinary shareholders |  | $ | (2,272,267 | ) |  | $ | 554,366 |  |  | a, b, c |  | $ | (1,717,901 | )
Weighted average number of ordinary shares outstanding - basic and diluted* |  |  | 137,750,000 |  |  |  | - |  |  |  |  |  | 137,750,000 |
Loss per ordinary share - basic and diluted |  | $ | (0.02 | ) |  | $ | 0.01 |  |  | a, b, c |  | $ | (0.01 | )
* | Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4.
Schedule of Consolidated Statements of Cash Flows | Summary of Restatements - Unaudited Condensed Consolidated Statements of Cash Flows:
|  | For the Nine Months Ended June 30, 2024 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (14,156,518 | ) |  | $ | (2,536,289 | ) |  | a, b, e |  | $ | (16,692,807 | )
Adjustments to reconcile net loss to net cash used in operating activities. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization expense |  |  | 323,772 |  |  |  | (323,696 | ) |  | a, e |  |  | 76 |
Depreciation expense |  |  | 3,870 |  |  |  | (12 | ) |  | e |  |  | 3,858 |
Foreign currency translation |  |  | (29,994 | ) |  |  | 29,994 |  |  | e |  |  | - |
Changes in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |
Prepaid expenses |  |  | 125,596 |  |  |  | (32,110 | ) |  | d, e |  |  | 93,486 |
Advance to a related company |  |  | 97,882 |  |  |  | (529 | ) |  | e |  |  | 97,353 |
Deposits |  |  | (43,114 | ) |  |  | (763 | ) |  | e |  |  | (43,877 | )
Other receivables |  |  | (47,018 | ) |  |  | (337 | ) |  | e |  |  | (47,355 | )
Interests payable |  |  | 17,433 |  |  |  | (9 | ) |  | e |  |  | 17,424 |
Other payables |  |  | (289,900 | ) |  |  | 290,000 |  |  | d |  |  | 100 |
Accrued expenses |  |  | (878,520 | ) |  |  | 1,071,791 |  |  | d, e |  |  | 193,271 |
Related party payable |  |  | (88,542 | ) |  |  | 88,542 |  |  | d |  |  | - |
Deferred underwriting fee |  |  | (2,000,000 | ) |  |  | 2,000,000 |  |  | d |  |  | - |
Payable to directors |  |  | 2,463,297 |  |  |  | (2,463,297 | ) |  | a, c, d, e |  |  | - |
Provision for bonus |  |  | 10,154,677 |  |  |  | 3,645,323 |  |  | c |  |  | 13,800,000 |
Net cash used in operating activities |  |  | (4,347,079 | ) |  |  | 1,768,608 |  |  | a, b, c, d, e |  |  | (2,578,471 | )
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment |  |  | (1,271,043 | ) |  |  | (691 | ) |  | e |  |  | (1,271,734 | )
Net cash used in investing activities |  |  | (1,271,043 | ) |  |  | (691 | ) |  | e |  |  | (1,271,734 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of shares |  |  | 6,260,259 |  |  |  | (6,260,259 | ) |  | d |  |  | - |
Repayment of working capital loan |  |  | (555,358 | ) |  |  | 555,358 |  |  | d |  |  | - |
Proceeds from long-term debt - related party |  |  | - |  |  |  | 2,583,996 |  |  | c |  |  | 2,583,996 |
Repayments to long-term debt - related party |  |  | - |  |  |  | (105,988 | ) |  | c |  |  | (105,988 | )
Payments of deferred merger costs |  |  | - |  |  |  | (919,446 | ) |  | b, e |  |  | (919,446 | )
Proceeds from the completion of reverse recapitalization |  |  | - |  |  |  | 1,231 |  |  | d |  |  | 1,231 |
Proceeds from PIPE investment |  |  | - |  |  |  | 2,500,000 |  |  | b, c, d, e |  |  | 2,500,000 |
Net cash provided by financing activities |  |  | 5,704,901 |  |  |  | (1,645,108 | ) |  | b, c, d, e |  |  | 4,059,793 |
Effect of exchange rate changes |  |  | - |  |  |  | (122,809 | ) |  | e |  |  | (122,809 | )
Net change in cash |  |  | 86,779 |  |  |  | - |  |  |  |  |  | 86,779 |
Cash - beginning of the period |  |  | 1,430 |  |  |  | - |  |  |  |  |  | 1,430 |
Cash - end of the period |  | $ | 88,209 |  |  | $ | - |  |  |  |  | $ | 88,209 |
| Summary of Restatements - Consolidated Statements of Cash Flows:
|  | For the Year Ended September 30, 2023 |
|  | As previously reported |  |  | Adjustments |  |  | Reference |  | As restated |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (2,340,661 | ) |  | $ | 498,762 |  |  | a, b, c |  | $ | (1,841,899 | )
Adjustments to reconcile net loss to net cash used in operating activities. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization expense |  |  | 431,593 |  |  |  | (431,593 | ) |  | a |  |  | - |
Depreciation expense |  |  | 103 |  |  |  | - |  |  |  |  |  | 103 |
Changes in operating assets and liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |
Prepaid expenses |  |  | (77,215 | ) |  |  | - |  |  |  |  |  | (77,215 | )
Advance to a related company |  |  | 10,289 |  |  |  | - |  |  |  |  |  | 10,289 |
Deposits |  |  | (127,664 | ) |  |  | - |  |  |  |  |  | (127,664 | )
Other receivables |  |  | (34,183 | ) |  |  | - |  |  |  |  |  | (34,183 | )
Interests payable |  |  | 23,380 |  |  |  | - |  |  |  |  |  | 23,380 |
Other payables and accrued expenses |  |  | 119,147 |  |  |  | 41,450 |  |  | c |  |  | 160,597 |
Payable to directors |  |  | 1,704,724 |  |  |  | 592,191 |  |  | a |  |  | 2,296,915 |
Net cash provided by operating activities |  |  | (290,487 | ) |  |  | 700,810 |  |  | a, b, c |  |  | 410,323 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment |  |  | (1,598 | ) |  |  | - |  |  |  |  |  | (1,598 | )
Net cash used in investing activities |  |  | (1,598 | ) |  |  | - |  |  |  |  |  | (1,598 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payments of deferred merger costs |  |  | - |  |  |  | (700,810 | ) |  | b |  |  | (700,810 | )
Net cash used in financing activities |  |  | - |  |  |  | (700,810 | ) |  | b |  |  | (700,810 | )
Effect of exchange rate changes |  |  | 68,394 |  |  |  | - |  |  |  |  |  | 68,394 |
Net change in cash |  |  | (223,691 | ) |  |  | - |  |  |  |  |  | (223,691 | )
Cash - beginning of the year |  |  | 225,121 |  |  |  | - |  |  |  |  |  | 225,121 |
Cash - end of the year |  | $ | 1,430 |  |  | $ | - |  |  |  |  | $ | 1,430 |

X
- References No definition available. + Details
Name: | srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration